Efficacy of Na-GST-1/Alhydrogel Hookworm Vaccine Assessed by Controlled Challenge Infection
Status:
Active, not recruiting
Trial end date:
2022-08-17
Target enrollment:
Participant gender:
Summary
This study evaluates the efficacy, safety and immunogenicity of different formulations of the
Na-GST-1 hookworm vaccine using a controlled human hookworm infection model in healthy,
hookworm-naive adults.
Phase:
Phase 2
Details
Lead Sponsor:
Baylor College of Medicine
Collaborators:
George Washington University National Institute of Allergy and Infectious Diseases (NIAID)